|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-1-17
|
|
pubmed:abstractText |
To determine the maximum tolerated dose (MTD) of oral cisplatin (CP Ethypharm®) in combination with radiotherapy in head and neck squamous cell carcinoma (HNSCC) and the recommended dose for phase II trials.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1879-0887
|
|
pubmed:author |
pubmed-author:BourhisJeanJ,
pubmed-author:BrainEtienneE,
pubmed-author:Daly-SchveitzerNicolasN,
pubmed-author:EtessamiAtoussaA,
pubmed-author:LokiecFrançoisF,
pubmed-author:LusinchiAntoineA,
pubmed-author:RezaïKeyvanK,
pubmed-author:TaoYunganY,
pubmed-author:TemamStephaneS,
pubmed-author:UrienSaikS,
pubmed-author:VanMarie-Louise VoML,
pubmed-author:Vauzelle-KervroedanFrançoiseF
|
|
pubmed:copyrightInfo |
Copyright © 2010. Published by Elsevier Ireland Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
98
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
42-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21176985-Administration, Oral,
pubmed-meshheading:21176985-Carcinoma,
pubmed-meshheading:21176985-Carcinoma, Squamous Cell,
pubmed-meshheading:21176985-Cisplatin,
pubmed-meshheading:21176985-Combined Modality Therapy,
pubmed-meshheading:21176985-Female,
pubmed-meshheading:21176985-Head and Neck Neoplasms,
pubmed-meshheading:21176985-Humans,
pubmed-meshheading:21176985-Male,
pubmed-meshheading:21176985-Maximum Tolerated Dose,
pubmed-meshheading:21176985-Middle Aged,
pubmed-meshheading:21176985-Neoplasms, Squamous Cell,
pubmed-meshheading:21176985-Radiotherapy Dosage
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma.
|
|
pubmed:affiliation |
Institute Gustave-Roussy, Villejuif, France.
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase I
|
